GRITSTONE BIO INC. - COMMON STOCK

Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023

04 Apr 2023 18:30:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting

15 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

09 Mar 2023 16:05:01 By Nasdaq GlobeNewswire

Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 9, 2023

02 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference

27 Feb 2023 16:06:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

27 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination

14 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio to Participate in Upcoming Investor Conferences

18 Jan 2023 17:30:00 By Nasdaq GlobeNewswire

Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference

15 Dec 2022 16:31:00 By Nasdaq GlobeNewswire

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 Dec 2022 16:30:00 By Nasdaq GlobeNewswire

Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA)

13 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

21 Nov 2022 07:30:09 By Nasdaq GlobeNewswire

Gritstone to Participate in Upcoming Investor Conferences

17 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Gritstone Announces Updated Overall Survival Results from GRANITE Phase 1/2 Study and Poster at SITC 2022

10 Nov 2022 09:00:02 By Nasdaq GlobeNewswire

Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update

03 Nov 2022 16:05:03 By Nasdaq GlobeNewswire

Gritstone bio Announces Private Placement of $45.0 Million

25 Oct 2022 07:01:00 By Nasdaq GlobeNewswire

Gritstone Presents Positive Results from Two Phase 1 CORAL Studies, Providing Further Proof-of-Concept for Self-amplifying mRNA (samRNA) in Infectious Diseases

25 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Gritstone to Host Data Update on CORAL and Discuss the Application of Self-amplifying mRNA (samRNA) in Infectious Diseases

19 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17 Oct 2022 07:00:00 By Nasdaq GlobeNewswire